Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03043872 |
|---|---|
| Brief Title: | Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) (CASPIAN) |
| First Submitted : | January 18, 2017 |
| First Submitted that Met QC Criteria : | February 3, 2017 |
| First Posted : | February 6, 2017 (Estimate) |
| Results First Submitted : | January 21, 2021 |
| Results First Posted with QC Comments : | February 9, 2021 |
| Results First Submitted that Met QC Criteria : | February 10, 2021 |
| Results First Posted : | March 4, 2021 |
| Last Update Submitted that Met QC Criteria : | December 19, 2023 |
| Last Update Posted : | December 21, 2023 |